SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem

Instituto Costarricense de Investigaciones Clínicas ICIC

Overview

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

BioSafety Technologies has developed a rapid detection test to clear people of COVID-19. A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel. The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.

Study Type

OBSERVATIONAL

Conditions

COVID19

Interventions

Breath sampleDIAGNOSTIC_TEST

Patient will blow into a tube 5 times.

Eligibility

Sex: ALLMin age: 7 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Older than 7 years odf age Able to provide informed consent Able to take the breath test Exclusion Criteria: Younger than 7 years of age Unable to provide informed consent Unable to take the breath test

Locations (1)

Instituto Costarricense de Investigaciones Clínicas

San José, Costa Rica

Outcomes

Primary Outcomes

Presence of disease

Established diagnosis

Time frame: 1 minute

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.